While Bayer’s consumer and crop science divisions continued to slide—both in the fourth quarter and in 2024 overall—the company’s pharma division was able to eke out modest sales gains of ...

Open innovation in medical and pharmaceutical research has grown steadily over the last decade. However, the performance of the published literature in terms of the scientific impact and gaining ...

Crucially, the scale doesn't factor in the drugs' cost – but Europe's pharma representative body EFPIA is nevertheless less than impressed. Replying to an enquiry from pharmaphorum, EFPIA gave ...

Credit: JHVEPhoto/Shutterstock. Eli Lilly has announced plans to expand its domestic medicine production in the US by establishing four new pharmaceutical manufacturing sites. The move increases the ...

The two major pharma representative corporations in Europe and the US have strengthened their long-standing commitment to public health by welcoming independent reviews of clinical trial data.

HERZLIYA, Israel and CALGARY, AB, Jan. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a ...

Sun Pharmaceutical Industries Ltd aims to spend 7-8 per cent of its sales in the current fiscal on research and development activities as it looks to further strengthen its product portfolio across ...

Brad Setser’s testimony to the United States Senate Committee on Finance addresses pharmaceutical manufacturers and U.S. international tax policy. I want to thank Chairman Wyden, Ranking Member ...

Following an approval from the US Food and Drug Administration (FDA), Lupin Limited on Thursday launched its antidepressant drug bupropion hydrochloride extended-release tablet (XL) in 150 mg and 300 ...